| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8814221 | Biological Psychiatry | 2018 | 61 Pages |
Abstract
Taken together, these results identified the miR-124/PTPN1 pathway as a critical mediator of synaptic dysfunction and memory loss in AD, and the miR-124/PTPN1 pathway could be considered as a promising novel therapeutic target for AD patients.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Xiong Wang, Dan Liu, He-Zhou Huang, Zhi-Hao Wang, Tong-Yao Hou, Xin Yang, Pei Pang, Na Wei, Ya-Fan Zhou, Marie-Josée Dupras, Frédéric Calon, Yu-Tian Wang, Heng-Ye Man, Jian-Guo Chen, Jian-Zhi Wang, Sébastien S. Hébert, Youming Lu, Ling-Qiang Zhu,